Vivimed Labs Balance Sheet Health
Financial Health criteria checks 0/6
Vivimed Labs has a total shareholder equity of ₹394.2M and total debt of ₹3.8B, which brings its debt-to-equity ratio to 960.3%. Its total assets and total liabilities are ₹9.9B and ₹9.5B respectively.
Key information
960.3%
Debt to equity ratio
₹3.79b
Debt
| Interest coverage ratio | n/a |
| Cash | ₹37.62m |
| Equity | ₹394.23m |
| Total liabilities | ₹9.49b |
| Total assets | ₹9.88b |
Recent financial health updates
Is Vivimed Labs (NSE:VIVIMEDLAB) Weighed On By Its Debt Load?
Mar 30
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Dec 14Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Nov 25
Is Vivimed Labs (NSE:VIVIMEDLAB) Using Debt In A Risky Way?
Jul 31Recent updates
Is Vivimed Labs (NSE:VIVIMEDLAB) Weighed On By Its Debt Load?
Mar 30Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Dec 14Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)
Jun 30Estimating The Intrinsic Value Of Vivimed Labs Limited (NSE:VIVIMEDLAB)
Feb 22Did Vivimed Labs Limited (NSE:VIVIMEDLAB) Insiders Buy Up More Shares?
Jan 19Is Vivimed Labs (NSE:VIVIMEDLAB) Using Too Much Debt?
Nov 25Are Insiders Buying Vivimed Labs Limited (NSE:VIVIMEDLAB) Stock?
Sep 22Is Vivimed Labs (NSE:VIVIMEDLAB) Using Debt In A Risky Way?
Jul 31Financial Position Analysis
Short Term Liabilities: VIVIMEDLAB's short term assets (₹3.3B) do not cover its short term liabilities (₹4.2B).
Long Term Liabilities: VIVIMEDLAB's short term assets (₹3.3B) do not cover its long term liabilities (₹5.2B).
Debt to Equity History and Analysis
Debt Level: VIVIMEDLAB's net debt to equity ratio (950.7%) is considered high.
Reducing Debt: VIVIMEDLAB's debt to equity ratio has increased from 58% to 960.3% over the past 5 years.
Debt Coverage: VIVIMEDLAB's debt is not well covered by operating cash flow (9.3%).
Interest Coverage: Insufficient data to determine if VIVIMEDLAB's interest payments on its debt are well covered by EBIT.